ArticleFrontiers in genetics2022

Angiogenic Factor-Based Signature Predicts Prognosis and Immunotherapy Response in Non-Small-Cell Lung Cancer.

Xinpei Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.